Triple Threat to Cancer: Rationale for Combining Oncolytic Viruses, MEK Inhibitors, and Immune Checkpoint Blockade
OncoImmunology - United States
doi 10.1080/2162402x.2019.1571390
Full Text
Open PDFAbstract
Available in full text
Date
February 3, 2019
Authors
Publisher
Informa UK Limited